Xylem raises full-year EPS guidance on 42% order growth and margin expansion

Filed July 28, 2026 · Period ending July 28, 2026 · ~1 min read

Key Changes

• high

  Q2 orders surged 42% (41% organic) to $3.1B while revenue grew 2% (1% organic) to $2.3B; adjusted EPS rose 16% to $1.46, beating on margin expansion despite modest top-line growth.

  Exhibit 99.1 view on EDGAR →
• high

  Adjusted EBITDA margin expanded 150 basis points year-over-year to 23.3% in Q2, driven by productivity savings and price realization that more than offset inflation and lower volumes.

  Exhibit 99.1 view on EDGAR →
• high

  Full-year 2026 adjusted EPS guidance raised to $5.55–$5.70 from prior $5.35–$5.60; adjusted EBITDA margin expected at 23.1–23.5% (up 90–130 bps year-over-year).

  Exhibit 99.1 view on EDGAR →